{"id":"https://openalex.org/W4403081699","doi":"https://doi.org/10.1016/j.clml.2024.09.011","title":"The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator","display_name":"The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403081699","doi":"https://doi.org/10.1016/j.clml.2024.09.011","pmid":"https://pubmed.ncbi.nlm.nih.gov/39477702"},"language":"en","primary_location":{"id":"doi:10.1016/j.clml.2024.09.011","doi":"https://doi.org/10.1016/j.clml.2024.09.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2024.09.011","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(24)02356-5/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(24)02356-5/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Monica Mead","orcid":"https://orcid.org/0000-0001-9175-0189","observed_orcids":["https://orcid.org/0000-0001-9175-0189"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Monica Mead","raw_affiliation_strings":["Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA. Electronic address: monicadmead@gmail.com"],"raw_orcid":"https://orcid.org/0000-0001-9175-0189","affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA. Electronic address: monicadmead@gmail.com","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039860428","display_name":"Beth A. Glenn","orcid":"https://orcid.org/0000-0002-4937-8181","observed_orcids":["https://orcid.org/0000-0002-4937-8181"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Glenn","raw_affiliation_strings":["Health Policy and Management, UCLA Jonsson Comprehensive Cancer Center, UCLA Kaiser Permanente Center for Health Equity, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0002-4937-8181","affiliations":[{"raw_affiliation_string":"Health Policy and Management, UCLA Jonsson Comprehensive Cancer Center, UCLA Kaiser Permanente Center for Health Equity, Los Angeles, CA","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044602269","display_name":"Joe Tuscano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe Tuscano","raw_affiliation_strings":["Interim Director of Bone Marrow and Stem Cell Transplantation, UC Davis Comprehensive Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interim Director of Bone Marrow and Stem Cell Transplantation, UC Davis Comprehensive Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110457241","display_name":"Angshuman Saha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angshuman Saha","raw_affiliation_strings":["Division of General Internal Medicine and Health Services Research, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of General Internal Medicine and Health Services Research, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Larson","raw_affiliation_strings":["Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072955574","display_name":"Sophie G. Carlson","orcid":"https://orcid.org/0009-0007-6686-1494","observed_orcids":["https://orcid.org/0009-0007-6686-1494"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophie Carlson","raw_affiliation_strings":["Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102788819","display_name":"Jasmine M. Zain","orcid":"https://orcid.org/0000-0003-4308-629X","observed_orcids":["https://orcid.org/0000-0003-4308-629X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasmine Zain","raw_affiliation_strings":["Director of T-cell Lymphoma Program, City of Hope National Medical Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of T-cell Lymphoma Program, City of Hope National Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":3780,"currency":"USD","value_usd":3780},"apc_paid":{"value":3780,"currency":"USD","value_usd":3780},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23557077,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"3","first_page":"162","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/social-determinants-of-health","display_name":"social determinants of health","score":0.996999979019165},{"id":"https://openalex.org/keywords/lymphoma-specific-survival","display_name":"lymphoma-specific survival","score":0.8009999990463257},{"id":"https://openalex.org/keywords/socioeconomic-status","display_name":"socioeconomic status","score":0.640999972820282},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.5329999923706055},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.7910000085830688},{"id":"https://openalex.org/keywords/health-insurance-status","display_name":"health insurance status","score":0.5509999990463257},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.40799999237060547},{"id":"https://openalex.org/keywords/educational-attainment","display_name":"educational attainment","score":0.5559999942779541},{"id":"https://openalex.org/keywords/urban-rural-differences","display_name":"urban-rural differences","score":0.7319999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.753000020980835},{"id":"https://openalex.org/keywords/survival-disparities","display_name":"survival disparities","score":0.3700000047683716},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.6740000247955322},{"id":"https://openalex.org/keywords/primary-cutaneous-t-cell-lymphoma","display_name":"primary cutaneous T-cell lymphoma","score":0.6200000047683716},{"id":"https://openalex.org/keywords/angioimmunoblastic-t-cell-lymphoma","display_name":"angioimmunoblastic T-cell lymphoma","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9516018629074097},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.5634872913360596},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.518439531326294},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.4997859001159668},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4681810438632965},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.465268611907959},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3621724545955658},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.32428911328315735},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D064890","descriptor_name":"Social Determinants of Health","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.clml.2024.09.011","doi":"https://doi.org/10.1016/j.clml.2024.09.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2024.09.011","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(24)02356-5/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},{"id":"doi:10.2139/ssrn.4897282","doi":"https://doi.org/10.2139/ssrn.4897282","is_oa":true,"landing_page_url":"http://dx.doi.org/10.2139/ssrn.4897282","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:39477702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39477702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical lymphoma, myeloma & leukemia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.clml.2024.09.011","doi":"https://doi.org/10.1016/j.clml.2024.09.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2024.09.011","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(24)02356-5/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0},{"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10","score":0.7578999996185303}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332502","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60"},{"id":"https://openalex.org/F4320337550","display_name":"Jonsson Comprehensive Cancer Center","ror":"https://ror.org/046rm7j60"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403081699.pdf","grobid_xml":"https://content.openalex.org/works/W4403081699.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1590827989","https://openalex.org/W1759784408","https://openalex.org/W1956179020","https://openalex.org/W2021464413","https://openalex.org/W2083358890","https://openalex.org/W2133267160","https://openalex.org/W2163510906","https://openalex.org/W2264394109","https://openalex.org/W2373350042","https://openalex.org/W2416844197","https://openalex.org/W2461880309","https://openalex.org/W2514775182","https://openalex.org/W2800928008","https://openalex.org/W2890053473","https://openalex.org/W2908712589","https://openalex.org/W2915720971","https://openalex.org/W2947954028","https://openalex.org/W2990669141","https://openalex.org/W3002103692","https://openalex.org/W3037687286","https://openalex.org/W3091962037","https://openalex.org/W3093094381","https://openalex.org/W3126876380","https://openalex.org/W3197734660","https://openalex.org/W4205839367","https://openalex.org/W4210295219","https://openalex.org/W4283327547","https://openalex.org/W4286771143","https://openalex.org/W4366821731","https://openalex.org/W4386216076"],"related_works":["https://openalex.org/W4410822447","https://openalex.org/W2021464413","https://openalex.org/W4413781887","https://openalex.org/W4281678684","https://openalex.org/W2133267160","https://openalex.org/W4407835312","https://openalex.org/W2989450426","https://openalex.org/W2584462338","https://openalex.org/W2101648597","https://openalex.org/W4379346383"],"abstract_inverted_index":{"Abstract":[0],"BackgroundPrognostic":[1],"models":[2,105],"in":[3,86,141,338,376],"peripheral":[4],"T":[5],"cell":[6],"lymphoma":[7],"(PTCL)":[8],"have":[9],"identified":[10],"biological":[11],"factors":[12,126,139,194],"including":[13],"age,":[14],"performance":[15],"status,":[16],"LDH,":[17],"and":[18,69,78,91,98,124,136,167,182,186,218,270,320,358],"bone":[19],"marrow":[20],"involvement":[21],"as":[22,360],"prognostic":[23,324,372],"for":[24,95,101,325,365,401],"survival.":[25],"The":[26],"association":[27,373],"of":[28,34,46,384],"nonbiological":[29],"factors,":[30],"termed":[31],"social":[32],"determinants":[33],"health":[35],"(SDH),":[36],"on":[37,49],"PTCL":[38,50,74,366,378,385,403],"outcomes":[39,400],"remains":[40],"unexplored.":[41],"MethodsTo":[42],"evaluate":[43],"the":[44,152,172,271,278,311,370],"impact":[45],"actionable":[47,363],"SDH":[48,364],"mortality":[51,102,386],"across":[52],"race":[53,208],"groups,":[54],"we":[55],"conducted":[56],"a":[57,132,145,335,381],"retrospective":[58],"cohort":[59],"study":[60],"that":[61],"included":[62,106,158,202],"all":[63,402],"White,":[64,162],"Hispanic,":[65,164],"Asian/Pacific":[66],"Islander":[67],"(PI)":[68],"Black":[70],"adult":[71],"patients":[72],"with":[73,197,205,221,259,334,374],"(AITL,":[75],"ALCL,":[76],"NKTCL":[77],"PTCL,":[79,222],"NOS),":[80],"diagnosed":[81],"from":[82],"2000":[83],"to":[84,246,277,395],"2020,":[85],"California.":[87],"We":[88],"utilized":[89],"Chi2":[90],"Wilcoxon":[92],"rank-sum":[93],"tests":[94],"descriptive":[96],"metrics":[97],"Kaplan-Meier":[99],"statistics":[100],"estimation.":[103],"Regression":[104],"patient-":[107],"(age,":[108],"sex,":[109],"race,":[110],"stage,":[111],"Charlson":[112],"Comorbidity":[113],"Index,":[114],"histology,":[115,315],"treatment":[116,118,317,355],"type,":[117],"at":[119,144,328,392],"an":[120,329,361],"academic":[121,244,330,396],"center,":[122],"payer),":[123],"neighborhood-level":[125],"(socioeconomic":[127],"(SES)":[128],"quintile,":[129],"proportion":[130],"without":[131],"high":[133],"school":[134],"diploma,":[135],"rural/urban).":[137],"Risk":[138,193],"significant":[140],"univariate":[142],"regression":[143],"P-value":[146],"<":[147,255,268,308,350],"0\u00b710":[148],"were":[149,322],"incorporated":[150],"into":[151],"multivariable":[153],"model.":[154],"Findings":[155],"Our":[156],"analysis":[157],"6,158":[159],"patients:":[160],"51\u00b78%":[161],"25\u00b78%":[163],"14\u00b77%":[165],"Asians/PI,":[166],"7\u00b76%":[168],"Black.":[169],"Hispanics":[170],"exhibited":[171],"longest":[173],"median":[174],"survival":[175,200],"(33":[176],"months)":[177],"followed":[178],"by":[179,387],"Whites,":[180],"Blacks,":[181],"Asian/PI":[183,203],"(25,":[184],"20,":[185],"14":[187],"months,":[188,344],"respectively;":[189],"P":[190,214,231,241,254,267,288,298,307,349],"=":[191,215,232,242,289,299,346],"0\u00b7011).":[192],"independently":[195,323],"associated":[196,333],"inferior":[198],"lymphoma-specific":[199],"(LSS)":[201],"compared":[204,220,245,258,276],"NH":[206],"White":[207],"(HR,":[209],"1\u00b723;":[210],"95%":[211,228,238,251,264,285,294,304],"CI,":[212,229,252],"1\u00b710-1\u00b734;":[213],"0\u00b70002),":[216],"AITL":[217],"ALCL":[219,235],"NOS":[223],"histology":[224],"(AITL":[225],"HR,":[226,236],"1\u00b714;":[227,293],"1\u00b702-1\u00b725;":[230],"0\u00b7011":[233],";":[234],"1\u00b715;":[237],"CI":[239,265,286,295,305],"1\u00b704-1\u00b726;":[240],"0\u00b7004),":[243],"non-academic":[247],"facility-type":[248],"(HR":[249,262],"0\u00b771;":[250],"0\u00b764-0\u00b777;":[253],"0\u00b701),":[256,269],"Medicare":[257],"uninsured":[260],"status":[261],"1\u00b748,":[263],"1\u00b725-1\u00b773;":[266],"lowest":[272],"three":[273],"education":[274,280,321],"quartiles":[275],"highest":[279],"quartile":[281],"(Q2":[282],"HR":[283,292,302],"1\u00b713;":[284],"1\u00b701-1\u00b725;":[287],"0\u00b7021;":[290],"Q3":[291],"1\u00b702-":[296],"1\u00b726;":[297],"0\u00b7018;":[300],"Q4":[301],"1\u00b722;":[303],"1\u00b708-1\u00b736;":[306],"0\u00b7001).":[309],"In":[310],"least":[312],"resourced":[313],"patients,":[314],"treatment,":[316],"facility-type,":[318,356],"payer":[319,357],"LSS.":[326],"Treatment":[327],"institution":[331],"was":[332],"striking":[336],"improvement":[337],"LSS":[339,375],"(academic":[340],"institution:":[341],"yes=":[342],"101":[343],"no":[345],"17":[347],"months;":[348],"0\u00b701)":[351],"InterpretationThese":[352],"data":[353],"identify":[354],"education,":[359],"independent":[362],"mortality.Treatment":[367],"center-type":[368],"had":[369],"strongest":[371],"our":[377],"cohort,":[379],"conferring":[380],"risk":[382],"reduction":[383],"nearly":[388],"30%.":[389],"Interventions":[390],"targeted":[391],"improving":[393],"access":[394],"centers":[397],"may":[398],"improve":[399],"patients.Funding":[404],"Jonsson":[405],"Comprehensive":[406],"Cancer":[407],"Center":[408],"Strategic":[409],"Plan-aligned":[410],"program":[411]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-10-03T00:00:00"}